Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound.

NCT04853914 is registered in ClinicalTrials.gov with EDAP TMS S.A. as lead sponsor.

NCT NCT04853914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04853914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound.
Lead sponsor
EDAP TMS S.A.
Phase
Not applicable
Overall status
Completed
Start date
September 13, 2021
Completion date
March 31, 2024
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia